Search Results - Bacquet-Deschryver, Helene

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Septic interspinous bursitis

    Septic interspinous bursitis by Protat, Pierre, Kaïci, Juliette, Michaud, Julien, Nicolau, Julia, Bacquet-Deschryver, Hélène

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  2. 2
    Paradoxical adverse events of anti-tumour necrosis factor therapy for spondyloarthropathies: a retrospective study

    Paradoxical adverse events of anti-tumour necrosis factor therapy for spondyloarthropathies: a retrospective study by Fouache, Damien, Goëb, Vincent, Massy-Guillemant, Nathalie, Avenel, Gilles, Bacquet-Deschryver, Helene, Kozyreff-Meurice, Macha, Ménard, Jean-François, Muraine, Marc, Savoye, Guillaume, Le Loët, Xavier, Tharasse, Christine, Vittecoq, Olivier

    Published in Rheumatology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    A 3 mg/kg starting dose of infliximab in active spondyloarthritis resistant to conventional treatments is efficient, safe and lowers costs

    A 3 mg/kg starting dose of infliximab in active spondyloarthritis resistant to conventional treatments is efficient, safe and lowers costs by Tenga, Ginette, Goëb, Vincent, Lequerré, Thierry, Bacquet-Deschryver, Hélène, Daragon, Alain, Pouplin, Sophie, Lanfant-Weybel, Karine, Le Loët, Xavier, Dieu, Bernard, Vittecoq, Olivier

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Bursite interépineuse septique

    Bursite interépineuse septique by Protat, Pierre, Kaici, Juliette, Michaud, Julien, Nicolau, Julia, Bacquet-Deschryver, Hélène

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  5. 5
    A 3mg/kg starting dose of infliximab in active spondyloarthritis resistant to conventional treatments is efficient, safe and lowers costs

    A 3mg/kg starting dose of infliximab in active spondyloarthritis resistant to conventional treatments is efficient, safe and lowers costs by Tenga, Ginette, Goëb, Vincent, Lequerré, Thierry, Bacquet-Deschryver, Hélène, Daragon, Alain, Pouplin, Sophie, Lanfant-Weybel, Karine, Le Loët, Xavier, Dieu, Bernard, Vittecoq, Olivier

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    L'infliximab à 3 mg/kg en dose initiale dans la spondylarthrite active résistante aux traitements habituels est efficace, bien toléré et moins coûteux

    L'infliximab à 3 mg/kg en dose initiale dans la spondylarthrite active résistante aux traitements habituels est efficace, bien toléré et moins coûteux by TENGA, Ginette, GOËB, Vincent, LEQUERRE, Thierry, BACQUET-DESCHRYVER, Hélène, DARAGON, Alain, POUPLIN, Sophie, LANFANT-WEYBEL, Karine, LE LOËT, Xavier, DIEU, Bernard, VITTECOQ, Olivier

    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    L’infliximab à 3mg/kg en dose initiale dans la spondylarthrite active résistante aux traitements habituels est efficace, bien toléré et moins coûteux

    L’infliximab à 3mg/kg en dose initiale dans la spondylarthrite active résistante aux traitements habituels est efficace, bien toléré et moins coûteux by Tenga, Ginette, Goëb, Vincent, Lequerré, Thierry, Bacquet-Deschryver, Hélène, Daragon, Alain, Pouplin, Sophie, Lanfant-Weybel, Karine, Le Loët, Xavier, Dieu, Bernard, Vittecoq, Olivier

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: